Skip to main content
MITECH CO.,LTD. logo

MITECH CO.,LTD. — Investor Relations & Filings

Ticker · 179290 ISIN · KR7179290002 KO Manufacturing
Open in API
Filings indexed 204 across all filing types
Latest filing 2021-07-28 Director's Dealing
Country KR South Korea
Listing KO 179290

About MITECH CO.,LTD.

https://www.mitech.co.kr/

MITECH CO.,LTD. is a global medical device company specializing in the development and manufacturing of innovative healthcare solutions. The company is a recognized leader in the field of non-vascular stents, providing a range of products for gastrointestinal and urologic procedures. Its core offerings, including the HANAROSTENT product line, are designed for use in digestive endoscopy for applications such as esophageal, biliary, and pyloric stenting. MITECH focuses on creating and supplying reliable medical instruments to healthcare providers worldwide.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. This document details the acquisition of shares by an executive (Jung Chun-soon) of Mitech Co., Ltd. In the context of financial filings, reports detailing personal share transactions by company directors and executives are classified as 'Director's Dealing'.
2021-07-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (Korea). It details the acquisition of shares by an executive (Park Young-woo) of Mitech Co., Ltd. This type of filing is a standard regulatory disclosure for insider trading or changes in executive shareholdings, which falls under the 'Director's Dealing' category.
2021-07-27 Korean
투자판단관련주요경영사항(HANAROSTENT Esophagus (CCC),HANAROSTENT Esophagus (NCN) FDA 품목허가 취득)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from a Korean company (M.I.Tech) announcing the receipt of FDA approval for specific medical devices (HANAROSTENT). It is a formal disclosure of a material business event ('투자판단 관련 주요경영사항') that does not fit into specific categories like financial reports, dividends, or M&A. Therefore, it falls under the general regulatory filing category.
2021-07-26 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company '엠아이텍' (M.I.TECH) covering the period from 2021-01-01 to 2021-03-31. It contains detailed corporate information, history, capital structure, and management details, which are characteristic of a formal quarterly financial report filed with the Korean financial authorities (Financial Services Commission/Korea Exchange). It is not a mere announcement or certification, but the report itself. Q1 2021
2021-05-14 Korean
투자판단관련주요경영사항(HANAROSTENT Benefit biliary (NNN))
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'major management matter' (투자판단 관련 주요경영사항). It announces that the company, M.I.Tech, has received FDA approval for a medical device (HANAROSTENT Benefit biliary). Since this is a specific regulatory announcement of a material business event that does not fit into categories like financial reports, dividends, or board changes, it is classified as a Regulatory Filing (RNS).
2021-05-12 Korean
[기재정정]투자판단관련주요경영사항(HANAROSTENT Benefit Biliary (NNN) FDA 품목허가취득)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Correction Report' (정정신고) for a previous disclosure about an FDA product approval. It details specific corrections to typos and capitalization in a prior announcement. Since it is a formal regulatory disclosure regarding company operations and product approvals that does not fit into specific categories like financial reports or shareholder meetings, it is classified as a general regulatory filing.
2021-05-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.